Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 1,558.58 | 1,191.20 | 951.08 | 936.91 |
Total Revenue | 1,558.58 | 1,191.20 | 951.08 | 936.91 |
Costof Revenue Total | 733.80 | 605.62 | 527.26 | 531.99 |
Gross Profit | 824.78 | 585.58 | 423.81 | 404.93 |
Selling/ General/ Admin Expenses Total | 257.06 | 277.38 | 253.11 | 117.87 |
Depreciation/ Amortization | 59.70 | 52.46 | 48.78 | 39.68 |
Other Operating Expenses Total | 105.13 | 5.35 | 5.63 | 4.90 |
Total Operating Expense | 1,155.69 | 960.93 | 855.59 | 827.34 |
Operating Income | 402.89 | 230.27 | 95.49 | 109.58 |
Interest Inc( Exp) Net- Non- Op Total | -139.97 | -170.63 | -78.40 | -123.20 |
Other Net | 12.54 | 3.41 | -3.68 | 8.35 |
Net Income Before Taxes | 401.44 | 215.75 | 82.16 | 105.33 |
Provisionfor Income Taxes | 101.36 | 52.23 | 18.34 | 24.70 |
Net Income After Taxes | 300.08 | 163.52 | 63.82 | 80.63 |
Net Income Before Extra Items | 300.08 | 163.52 | 63.82 | 80.63 |
Net Income | 300.08 | 163.52 | 63.82 | 80.63 |
Income Availableto Com Excl Extra Ord | 300.08 | 163.52 | 63.82 | 80.63 |
Income Availableto Com Incl Extra Ord | 300.08 | 163.52 | 63.82 | 80.63 |
Diluted Net Income | 300.08 | 163.52 | 63.82 | 80.63 |
Diluted Weighted Average Shares | 1.28 | 1.28 | 1.28 | 1.28 |
Diluted EPS Excluding Extra Ord Items | 233.89 | 127.45 | 49.74 | 62.85 |
DPS- Common Stock Primary Issue | 14.00 | 10.00 | 5.00 | 5.00 |
Diluted Normalized EPS | 233.89 | 127.96 | 50.84 | 63.01 |
Research Development | - | 198.08 | 205.43 | 1,328.95 |
Interest Exp( Inc) Net- Operating Total | - | 3.15 | 2.62 | - |
Gain( Loss)on Saleof Assets | - | -8.71 | -18.08 | -2.73 |
Total Extraordinary Items | - | - | - | 0.00 |
Neuland Laboratories Dividend Neuland Laboratories Bonus Neuland Laboratories News Neuland Laboratories AGM Neuland Laboratories Rights Neuland Laboratories Splits Neuland Laboratories Board Meetings Neuland Laboratories Key Metrics Neuland Laboratories Shareholdings Neuland Laboratories Balance Sheet Neuland Laboratories Cashflow Neuland Laboratories Q1 Results Neuland Laboratories Q2 Results Neuland Laboratories Q3 Results Neuland Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks